DEF 14C: Avenue Therapeutics Plans Reverse Stock Split to Regain Nasdaq Compliance

Avenue Therapeutics' board of directors has approved a reverse stock split, ranging from 30-for-1 to 75-for-1, to increase its stock price and maintain its Nasdaq listing.

Summary

• Avenue Therapeutics intends to implement a reverse stock split of its common stock.
• The reverse stock split ratio will be between 30-for-1 and 75-for-1, with the exact ratio to be determined by the board of directors.
• Stockholders holding approximately 56% of the voting power approved the reverse stock split via written consent on March 6, 2024.
• The company's board of directors approved the reverse stock split.
• The reverse stock split aims to increase the market price of the common stock.
• The effective date of the reverse stock split will be no earlier than April 8, 2024.
• No fractional shares will be issued; instead, fractional shares will be rounded up to the next whole share.
• The company is not reducing the number of authorized shares of common stock.
• The company's common stock will continue to be quoted on the Nasdaq Capital Market.
• The company plans to continue to file periodic and other reports with the SEC under the Exchange Act.

Sentiment

Score: 5

Explanation: The document is neutral in tone, primarily conveying information about a corporate action. While the reverse stock split aims to improve the company's position, it also carries potential risks and uncertainties.

Positives

• The reverse stock split is intended to increase the market price of the common stock, which could help the company maintain its Nasdaq listing.
• The board of directors retains the flexibility to abandon the reverse stock split if it is no longer in the best interests of the stockholders.
• Stockholders' proportionate interest in the company will not be affected by the reverse stock split, except for minor differences resulting from the treatment of fractional shares.
• The company will continue to be quoted on the Nasdaq Capital Market and file reports with the SEC.

Negatives

• There is no guarantee that the reverse stock split will result in a sustained increase in the market price of the common stock.
• The reverse stock split may increase the number of stockholders who own odd lots, which could increase the cost of selling their shares.
• The reduction in the number of outstanding shares could adversely affect the market for the common stock by reducing liquidity.
• The availability of authorized but unissued shares could be used by management to oppose a hostile takeover attempt.

Risks

• The market price of the common stock may decline after the implementation of the reverse stock split.
• The reduction in the number of outstanding shares may adversely affect the market for the common stock by reducing the relative level of liquidity.
• The company's authorized and unissued shares could possibly be used by management to oppose a hostile takeover attempt, delay or prevent changes of control, or changes in or removal of management.
• There is no assurance that the reverse stock split will achieve the desired results.

Future Outlook

The board of directors will have the authority to effect the reverse stock split after a 20-day waiting period following the mailing of the information statement, but reserves the right not to proceed if it's not in the best interests of stockholders.

Management Comments

• Our board of directors determined to pursue stockholder action by majority written consent of those shares entitled to vote in an effort to reduce the costs and management time required to hold a special meeting of stockholders and to implement the above action in a timely manner.
• The company believes that granting this discretion provides our board of directors with maximum flexibility to act in the best interests of our stockholders.

Industry Context

Reverse stock splits are often used by companies whose stock price has fallen below a certain threshold, such as the minimum bid price required for continued listing on exchanges like Nasdaq. This action aims to increase the stock price and regain compliance.

Comparison to Industry Standards

• Reverse stock splits are a relatively common corporate action for companies facing delisting from exchanges due to low stock prices.
• Similar companies that have recently undertaken reverse stock splits include those in the biotechnology and pharmaceutical sectors facing regulatory or clinical trial setbacks.
• The typical range for reverse stock splits is between 1-for-2 and 1-for-10, but Avenue Therapeutics is considering a more aggressive range of 30-for-1 to 75-for-1, indicating a more significant need to boost its stock price.

Stakeholder Impact

• The reverse stock split will decrease the number of outstanding shares of common stock, but will not significantly affect any stockholder's proportionate interest in the company, except for possible minor differences resulting from the treatment of any fractional shares.
• The reverse stock split may increase the number of stockholders who own odd lots, which could increase the cost of selling their shares.
• The company expects that its Common Stock will continue to be quoted on the Nasdaq Capital Market as a fully reporting company and it plans to continue to file periodic and other reports with the SEC under the Exchange Act.

Next Steps

• The board of directors will determine the exact reverse stock split ratio within the approved range.
• The company will file a Certificate of Amendment effecting the reverse stock split with the Secretary of State for the State of Delaware.
• The company will publicly announce additional details regarding the reverse stock split prior to the effective date.
• Transmittal forms will be mailed to holders of record for exchanging stock certificates.

Key Dates

Keywords

reverse stock split, common stock, Avenue Therapeutics, stockholders, Nasdaq, certificate of incorporation, voting power, shares